Inflammation and infection
A planned quantitative CRP test designed to give primary care a numeric inflammation marker in minutes.
Target
C-reactive protein (CRP)
Sample
Fingerstick whole blood, serum or plasma
Readout
Quantitative, mg/L (planned)
Status
Planned
Why it matters
CRP rises quickly with inflammation and infection. Point-of-care CRP is used in many countries to help decide when antibiotics are and are not needed for respiratory infections, supporting antibiotic stewardship. That use depends on a number, not a positive/negative line.
How OncoFirm will measure it
Quantitative CRP is designed to fit the thresholds clinicians use when deciding on antibiotics.
Every strip carries a fluorescent reference line of known brightness. Reading the test line against it corrects for reader and temperature drift, and the reader flags runs that did not flow correctly.
Each result is stored with the date, operator and lot, ready to share with a clinic record or laboratory system instead of being retyped by hand.
Where it's headed
01
Antibody pairs, fluorescent conjugates and strip layout are selected and tested against the target.
02
Strip, reagents and reader settings are optimized, and pilot lots are built.
03
Precision, linearity, interference and lot-to-lot consistency are measured against reference methods.
04
Performance is evaluated with clinical samples. First release is planned for research use only, followed by regulatory submissions.
Related assays
Development status. This assay and the OncoFirm platform are in development. They have not been cleared or approved by the FDA and are not available for sale. First products are planned for research use only. Descriptions reflect design goals, not demonstrated performance.
We welcome research, clinical, manufacturing and distribution partners. Tell us how this assay fits your work.